PHARMADAN A/S: Financial statements 2019
CVR: 26524938
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
PHARMADAN A/S (CVR 26524938) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 955,749 and a net result of DKK -799,804 compared with DKK -1,646,271 the year before. That is a decrease of 1.8% compared with the year before. Equity in the 2019 report amounted to DKK 2,635,144. The solvency ratio was 66.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 955,749
- Profit/Loss
- DKK -799,804
- Equity
- DKK 2,635,144
- Total Assets
- DKK 3,978,524
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 956K | -800K | 2.6M | 3 |
| 2018 | - | 973K | -1.6M | 3.4M | 4 |
| 2017 | - | 585K | -2.6M | -919K | 5 |
| 2016 | - | 1M | -2.7M | 1.7M | 6 |
| 2015 | - | -989K | -4M | -3.6M | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout PHARMADAN A/S
PHARMADAN A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 2002. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Peter Rørvig. The board consists of Helle Rørvig, Niels Ulrik Heine and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,382,654 and a net result of DKK -5,426,641 compared with DKK -5,113,611 the year before. Equity in the 2025 report amounted to DKK -18,955,125.